Nicotinic autoreceptor function in rat brain during maturation and aging: possible differential sensitivity to organophosphorus anticholinesterases
- PMID: 12453664
- DOI: 10.1016/s0009-2797(02)00121-7
Nicotinic autoreceptor function in rat brain during maturation and aging: possible differential sensitivity to organophosphorus anticholinesterases
Abstract
Acetylcholine (ACh) release is modulated pre-synaptically by both muscarinic and nicotinic receptor-mediated processes. While muscarinic autoreceptors inhibit ACh release, nicotinic autoreceptors enhance ACh release and thus disruption of these processes could potentially affect cholinergic toxicity following exposure to anticholinesterases. Marked age-related differences in sensitivity to some organophosphorus (OP) anticholinesterases have been reported. We compared nicotinic autoreceptor function (NAF) during maturation and aging and evaluated its potential modulation by the common OP insecticide, chlorpyrifos (CPF). Cortical synaptosomes were pre-loaded with [3H]choline, superfused (0.6 ml/min) with physiological buffer and [3H]ACh release was evoked with potassium (KCl, 9 mM), with or without co-addition of exogenous ACh to stimulate nicotinic autoreceptors. Fractions of perfusate were subsequently collected and area under the curve (AUC) for [3H] was analyzed by scintillation counting. The difference in evoked release due to co-addition of exogenous ACh was defined as NAF. Under these conditions, atropine (ATR, 0.1 microM) appeared requisite for NAF; thus this muscarinic antagonist was subsequently added to all perfusion buffers. In synaptosomes from adult tissues, exogenous ACh (3-100 microM) significantly increased release in a concentration-dependent manner. The nicotinic antagonist mecamylamine (MEC, 100 microM) substantially reduced the potassium-evoked release elicited by co-addition of ACh (10 microM). Interestingly, the nicotinic agonists nicotine (NIC) and dimethylphenylpiperazinium (DMPP; 0.1-10 microM) had no effect on release. The active metabolite of CPF (i.e. chlorpyrifos oxon (CPO), 1-10 microM) inhibited NAF in vitro. Maturation-related expression of NAF was noted (AUC with co-addition of 10 microM ACh: 7-day rats, 7+/-6; 21-day rats, 44+/-6; 90-day rats, 196+/-37; 24-month rats, 173+/-52). NAF was substantially reduced (67-91%) 96 h after maximum tolerated dosages of CPF in adult and aged rats (279 mg/kg, sc) but not in juveniles (127 mg/kg, sc), even though AChE inhibition was similar among the age groups (>80%). Together these data suggest that NAF is differentially expressed during maturation and that this neuromodulatory process may be selectively altered by some OP insecticides, potentially contributing to age-related differences in response to AChE inhibitors. As NAF has been postulated to be activated under conditions of 'impaired' cholinergic function, selective alteration of this pre-synaptic process by OP anticholinesterases may be also important in age-related conditions associated with cholinergic hypofunction.
Copyright 2002 Elsevier Science Ireland Ltd.
Similar articles
-
In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.Toxicol Appl Pharmacol. 2002 Jan 15;178(2):102-8. doi: 10.1006/taap.2001.9326. Toxicol Appl Pharmacol. 2002. PMID: 11814330
-
Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.J Neurochem. 1996 Nov;67(5):1974-81. doi: 10.1046/j.1471-4159.1996.67051974.x. J Neurochem. 1996. PMID: 8863503
-
Age-related effects of chlorpyrifos on acetylcholine release in rat brain.Neurotoxicology. 2001 Feb;22(1):39-48. doi: 10.1016/s0161-813x(00)00009-7. Neurotoxicology. 2001. PMID: 11307850
-
Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer's disease.Pharmacol Ther. 1997;74(3):333-47. doi: 10.1016/s0163-7258(97)00006-5. Pharmacol Ther. 1997. PMID: 9352588 Review.
-
Acetylcholine release from the central nervous system: a 50-year retrospective.Crit Rev Neurobiol. 2005;17(3-4):161-217. doi: 10.1615/critrevneurobiol.v17.i3-4.30. Crit Rev Neurobiol. 2005. PMID: 17341198 Review.
Cited by
-
Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems.Brain Res Bull. 2007 May 30;72(4-6):232-74. doi: 10.1016/j.brainresbull.2007.01.005. Epub 2007 Jan 25. Brain Res Bull. 2007. PMID: 17452286 Free PMC article.
-
Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist.Psychopharmacology (Berl). 2016 Mar;233(5):925-32. doi: 10.1007/s00213-015-4174-9. Epub 2015 Dec 10. Psychopharmacology (Berl). 2016. PMID: 26660295 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous